Showing results (1561-1570 of 6,509) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|May 11, 2026
Broader gene representation by whole-exome sequencing improves accuracy of tumor mutational burden assessment for selection of pembrolizumab immunotherapyMilan Radovich, James Wacker, Jeffrey Solzak, et al.Cancer Immunology, Immunotherapy : CII|May 24, 2026
Real-world efficacy and safety of immune checkpoint blockades in advanced urothelial carcinoma with histologic variant subtypes: the pembroblad studyKarim Amrane, Luca Campedel, Fabien Moinard-Butot, et al.Cancer Immunology, Immunotherapy : CII|May 22, 2026
TGF-β inhibition enhances anti-tumor immunity and sensitizes PD-1 blockade therapy of bone marrow-derived myofibroblasts-induced "immunotherapy resistance" tumor modelXin Cheng, Lina He, Cong Zhou, et al.Cancer Immunology, Immunotherapy : CII|May 20, 2026
β-hydroxybutyrate potentiates anti-tumor immunity by modulating cytotoxic CD8+ T cell responsesYupan Bai, Han Xue, Yujie Bao, et al.Cancer Immunology, Immunotherapy : CII|March 14, 2026
Photodynamic priming with Vitamin D and ALA-based PDT induces intratumoral immune cell recruitment and signaling pathway activation in cutaneous squamous cell carcinomaAlan S Shen, Sanjay Anand, Cheng-En Cheng, et al.Cancer Immunology, Immunotherapy : CII|March 2, 2026
CAR T cells derived from a novel, high-affinity anti-CLL-1 monoclonal antibody exhibit a significant anti-AML effectShuhei Kida, Makiko Suga, Yuta Yamaguchi, et al.Cancer Immunology, Immunotherapy : CII|March 9, 2026
Impact of proton pump inhibitors on immunotherapy is modulated by prior chemotherapy and linked to gut microbiome-immune cell signaturesAnnastasia Petouhoff, Ryan Hicks, Marium Husain, et al.Cancer Immunology, Immunotherapy : CII|March 7, 2026
A STING-activating biomimetic mineralized nanovaccine triggers robust anti-tumor immunitySuxing Tuo, Yihan Wang, Meng Tian, et al.Cancer Immunology, Immunotherapy : CII|June 12, 2026
Beyond radiation: immunological potentials of boron neutron capture therapyMuyasha Abulimiti, Yu Sugawara, Yinuo Li, et al.Cancer Immunology, Immunotherapy : CII|April 10, 2026
Comparative safety of PD-1 and PD-L1 inhibitors in advanced solid tumors: a real-world cohort study with competing risk analysisYu-Hsiang Shih, Shao-Jing Wang, Chun-Ting Fan, et al.Pageof 651